．zvyvw．wvyw．。、。uvwywyvwzy。。。·。。。。x。vx、αy。wv。uvz．x。“vxzvx”·
62
20181291ChinJAesthPlastSurg,Jan2018Vol.29No.1
commonearl-onsetadnrogeneticalopecia[J].AmJHumGenet,
,
2005,77(1):140-148.
11ProdiDA,PirastN,ManincheddaG,etal.EDA2Risassociatedith
,AAGA
androgeneticalopecia[J].JInvestDermatol,2008,128(9):2268-2270.
A
12ChaCH,PriceDK,TillC,etal.Finasterideconcentrationsand
DHT
prostatecancerrisk:resultsfromtheprostatecancerpreentiontrial[J].
T
PLoSOne,2015,10(5):e0126672.
A
13IrigMS.Safetconcernsregarding5reductaseinhibitorsfor
thetreatmentofandrogeneticalopecia[J].CurrOpinEndocrinol
DiabetesObes,2015,22(3):248-253.
1
14,.
AGA
[J].,2017,14(5):43-46,70.
1AAGA
15,,,.5%
[J].,2012,41(10):631-633.
16KantiV,HillmannK,KottnerJ,etal.Effectofminoidiltopicalfoamon
AGA,
frontotemporalanderteandrogeneticalopeciainmen:a104-eek
open-labelclinicaltrial[J].JEurAcadDermatolVenereol,2016,
AGA
30(7):1183-1189.
17,,,.
[J].,2013,10(2):14-15
18,,.
50[J].,2013,13(6):63.
19,,.
1,,,.320
[J].,2016,33(4):498-501.
[J].(),2009,30(5):
20.[J].
620-623.
,2013,8(3):245
2,,.201
21UmarS.Hairtransplantationinpatientsithinadequateheaddonor
[J].,2008,7(4):79,81.
supplusingnonheadhair:reportof3cases[J].AnnPlastSurg,
3,,,.
2011,67(4):332-335
DHT[J].,2010,7(3):20-21.
22,,,.
4,,.124
30[J].(),2015(4):101-103.
[J].2015,34(4):42-43.
23AciP,GuptaGK,ClarkJ,etal.Lo-leellaser(light)therapy(LLLT)
5,,.
fortreatmentofhairloss[J].LasersSurgMed,2014,46(2):144-151
[J].,2007,23(2):136-137.
6InuiS,ItamiS.Androgenactionsonthehumanhairfollicl24e:MontiD,TampucciS,BurgalassiS,etal.Topicalformulations
perspecties[J].EpDermatol,2013,22(3):168-171.
containingfinasteride.PartI:initropermeation/penetrationstudy
7InuiS,ItamiS.Molecularbasisofandrogeneticalopecia:from
andiniopharmacokineticsinhairlessrat[J].JPharmSci,2014,
androgentoparacrinemediatorsthroughdermalpapilla[J].J
103(8):2307-2314.
DermatolSci,2011,61(1):1-6.
25,,,.
8CecchinE,DeMattiaE,MaonG,etal.Apharmacogenetic
[J].,1999,13(1):16-17.
sureofandrogenreceptor(CAG)nand(GGN)npolmorphismsin
26FreundBJ,SchwartM.Treatmentofmalepatternbaldness
patientseperiencinglongtermsideeffectsafterfinasteride
ithbotulinumtoin:apilotstudy[J].PlastReconstrSurg,
discontinuation[J].IntJBiolMarkers,2014,29(4):310-316.
2010,126(5):246e-248e.
9EllisJA,StebbingM,HarrapSB.Polmorphismoftheandrogen
2017-10-11
receptorgeneisassociatedithmalepatternbaldness[J].JInvest
,,,.
Dermatol,2001,116(3):452-455.
[J].,2018,29(1):60-62.DOI:10.3969/j.issn.
10HillmerAM,HannekenS,RitmannS,etal.Geneticariationin
1673-7040.2018.01.019.
thehumanandrogenreceptorgeneisthemajordeterminantof
1990
·····································
|
|
